Guidelines for outpatient cancer care by community pharmacists

Abstract

Get full access to this article

View all access options for this article.

References

Cancer Drug Pipeline Information for Patient Advocacy Groups. Pan-Canadian oncology drug review. Available: https://www.cadth.ca/sites/default/files/pcodr/Communications/pCODR-CCAN_HTA_Pipeline.pdf (accessed Sep. 25, 2015).

ten Brinke

Broadfield

. Pharmacists’ readiness to practice to provide clinical care for patients receiving oral treatment for cancer. Hospital Pharmacy Residency Project. Halifax, Nova Scotia: Capital District Health Authority and Dalhousie University; 2014.

Abbott

Edwards

. Oral anti-cancer agents in the community setting: a survey of pharmacists in Newfoundland and Labrador. Can Pharm J (Ott) 2011;144(5):220-6.

Abbott

Edwards

Whalen

. Are community pharmacists equipped to ensure the safe use of anticancer oral therapy in the community setting? J Oncol Pharm Pract 2014;20(1):29-39.

National Institute for Occupational Safety and Health. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2012. Available: www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf (accessed Sep. 25, 2015).

National Institute for Occupational Safety and Health. Proposed additions and deletions to the NIOSH Hazardous Drug List 2014. Available: www.cdc.gov/niosh/docket/review/docket233/pdf/FRN_HD_LIST_2014.pdf (accessed Sep. 25, 2015).

Griffin

Gilbert

Broadfield

. ReCap: comparison of independent error checks for oral versus intravenous chemotherapy. J Oncol Pract 2016;12(2):168-9.

Cancer Care Nova Scotia. Systemic Therapy Program. Available: www.cancercare.ns.ca/en/home/healthprofessionals/stp/default.aspx (accessed Sep. 25, 2015).

Jeon

White

Hunt

. Optimizing the design of preprinted orders for ambulatory chemotherapy: combining oncology, human factors and graphic design. J Oncol Pract 2012;8(2):97-102.

10.

Nova Scotia College of Pharmacists. Standards of practice: general pharmacy practice. Available: www.nspharmacists.ca/wp-content/uploads/2015/08/SoP-PharmacyPracticeGeneralFNL.pdf (accessed Sep. 25, 2015).

11.

Haynes

Ackloo

Sahota

. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;(2):CD000011.

12.

Multinational Association of Supportive Care in Cancer. MASCC Oral Agent Teaching Tool (MOATT). Available: www.mascc.org/MOATT (accessed Sep. 25, 2015).

13.

National Association of Pharmacy Regulatory Authorities. Model standards for pharmacy compounding of non-hazardous sterile products. Draft 2 A. Available: https://pharmacists.ab.ca/sites/default/files/CompoundingNon_hazardousSterileProducts_ConsultationStds.pdf (accessed Sep. 25, 2015).

14.

U.S. Pharmacopeial Convention. General chapter <797> pharmaceutical compounding—sterile preparations. Available: www.usp.org/usp-nf/official-text/revision-bulletins/general-chapter-pharmaceutical-compounding-sterile-preparations (accessed Sep. 25, 2015).

15.

U.S. Pharmacopeial Convention. General chapter <800> hazardous drugs—handling in healthcare settings. Available: www.usp.org/usp-nf/notices/general-chapter-hazardous-drugs-handling-healthcare-settings (accessed Sep. 25, 2015).

16.

Cancer Care Nova Scotia. Pharmacy practice guide: safe handling—cancer medications in the community pharmacy. Available: www.cancercare.ns.ca/site-cc/media/cancercare/3Safe%20Handling.pdf (accessed Oct. 14, 2016).